IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL5.67▼ 0.02% USD/MXN18.61▲ 0.52% USD/CLP994.16▼ 0.13% USD/COP 3,303 — 0.00% USD/PEN3.41▲ 0.10% USD/ARS1,544▼ 0.02% USD/UYU 40.59 — 0.00% USD/PYG6,196— 0.00% USD/BOB 11.59 — 0.00% USD/DOP 60.59 — 0.00% USD/CRC 442.74 — 0.00% USD/GTQ 7.64 — 0.00% USD/HNL 26.91 — 0.00% USD/NIO 36.62 — 0.00% USD/VES911.74▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.69▲ 2.75% USD/TTD6.75— 0.00% EUR/BRL6.25▼ 0.04% BRENT 96.37 ▲ 0.55% WTI 89.08 ▲ 0.59% IRON ORE 161.91 — — COPPER 6.03 ▼ 0.86% GOLD 3,850 ▼ 0.93% SILVER 47.41 ▼ 3.32% SOY 1,226 ▼ 1.35% CORN 444.00 ▼ 0.34% WHEAT 589.25 ▼ 0.67% COFFEE 279.25 ▼ 0.34% SUGAR 18.40 ▲ 0.99% ORANGE JUICE 136.85 ▼ 2.91% COTTON 78.68 ▲ 0.01% COCOA 5,123 ▲ 1.13% BEEF 224.80 ▲ 2.70% CATTLE 335.35 ▼ 0.10% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00% IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL 5.67 ▼ 0.02% USD/MXN 18.59 ▲ 0.46% USD/CLP 994.16 ▼ 0.13% USD/COP 3,303 — 0.00% USD/PEN 3.41 ▲ 0.13% USD/ARS 1,544 ▼ 0.02% USD/UYU 40.59 — 0.00% USD/PYG 6,196 ▲ 3.06% USD/BOB 11.59 — 0.00% USD/DOP 60.59 — 0.00% USD/CRC 442.74 — 0.00% USD/GTQ 7.64 — 0.00% USD/HNL 26.91 — 0.00% USD/NIO 36.62 — 0.00% USD/VES 911.74 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 2.75% USD/TTD 6.75 ▲ 2.58% EUR/BRL 6.25 ▼ 0.04% BRENT 96.37 ▲ 0.55% WTI 89.08 ▲ 0.59% IRON ORE 161.91 — — COPPER 6.03 ▼ 0.86% GOLD 3,850 ▼ 0.93% SILVER 47.41 ▼ 3.32% SOY 1,226 ▼ 1.35% CORN 444.00 ▼ 0.34% WHEAT 589.25 ▼ 0.67% COFFEE 279.25 ▼ 0.34% SUGAR 18.40 ▲ 0.99% ORANGE JUICE 136.85 ▼ 2.91% COTTON 78.68 ▲ 0.01% COCOA 5,123 ▲ 1.13% BEEF 224.80 ▲ 2.70% CATTLE 335.35 ▼ 0.10% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00%
since 2009
Monday, November 16, 2026

Brazil Rolls Out a Home-Grown Single-Shot Dengue Vaccine

By · · 2 min read

The Butantan Institute in Brazil created a dengue vaccine that works well with one dose and was 79.6% effective over two years.

This could be a big step in fighting dengue if people actually take it.

Brazil’s current dengue vaccination campaign with a Japanese product started on February 9 but faced hurdles, as only 17% of doses found recipients a month later.

Free daily brief — no card needed
Get every Latest News story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

The new Brazilian vaccine is said to help everyone, even those who have never had the disease.

The National Bank for Economic and Social Development (BNDES) provided about 20 million USD for this. The vaccine uses weak versions of all four dengue types.

Brazil Rolls Out a Home-Grown Single-Shot Dengue Vaccine.
Brazil Rolls Out a Home-Grown Single-Shot Dengue Vaccine.
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

Brazil is currently facing a rise in dengue cases. From January to mid-March, there were 1.3 million likely cases.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Exxon gets Guyana approval for a gas project”

There were also 343 deaths. Another 775 deaths are still being looked into.

This vaccine is different from others in Brazil. It requires only one shot and is for people aged 2 to 59.

Fernanda Boulos, a top doctor at the institute, shared this info. She said these features make the Butantan vaccine unique.

The vaccine must pass more tests before the public can get it. It might be ready by 2025 through Brazil’s health system.

Researchers tested the vaccine on 16,235 people across Brazil. These people were between 2 and 59 years old.

The test lasted two years and showed strong protection for all ages. Adults had 90% protection, teens had 77.8%, and young children had 80.1%.

Brazil already has two approved dengue vaccines

Most side effects were mild or moderate. They included pain, redness, headaches, and tiredness. Very few had serious side effects. Less than 0.1% were affected, but they all recovered.

Brazil already has two approved dengue vaccines: QDenga from Japan’s Takeda and Dengvaxia from France’s Sanofi.

Dengue causes fever, body pain, rash, and headaches. It comes from one of four virus types. Sometimes, it can get very serious.

This can lead to bleeding, low blood pressure, or shock. This vaccine matters because it offers a simpler, wider-reaching solution to dengue prevention.

It connects to global health by offering a potential model for dengue vaccination worldwide.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.